Stefanie A. Nelson, Ph.D.
Program Director, Host Susceptibility Factors Branch
National Institutes of Health
National Cancer Institute
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
9609 Medical Center Drive, Rm. 3E106, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
telephone: (240) 276-6944
Genetic differences affecting cancer risk and response to treatment, understanding the function of cancer risk variants, and interactions between the germline and somatic cancer genomes
Ph.D. - Human Genetics
University of Michigan at Ann Arbor
B.S. - Microbiology
University of Illinois at Urbana-Champaign
Dr. Nelson is a Program Director in the Epidemiology and Genomics Research Program's Host Susceptibility Factors Branch. Her responsibilities include developing and managing a portfolio of grants that focuses on host factors affecting cancer risk.
Dr. Nelson came to EGRP from The Scientific Consulting Group where she was a Research Associate. In this capacity, she provided scientific support to several DCCPS programs, NCI's Division of Cancer Prevention (DCP), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). She previously worked as a scientist at Meso Scale Discovery where she identified novel activators and inhibitors of nuclear-factor kappa B (NF-KB) and developed assays to detect transcription factor and steroid hormone receptor DNA binding using the company's electrochemiluminescent detection technology. Earlier in her career, Dr. Nelson was a postdoctoral fellow in NCI's Laboratory of Cellular and Molecular Biology, where she studied signal transduction by growth factors implicated in cancer and identified new genes in growth factor signaling pathways.